Can a daily capsule boost good vaginal bacteria? new study investigates
NCT ID NCT07715058
First seen Jul 20, 2026 · Last updated Jul 23, 2026 · Updated 3 times
Summary
This trial investigates whether taking a daily food supplement called Hifas Intima for 12 weeks can change the types and amounts of bacteria living in the vagina of healthy women aged 18 to 45. The supplement contains mushroom extract, herbs, probiotics, and vitamins. Researchers measure changes in vaginal bacteria, pH, and overall vaginal health, and track any side effects. All participants receive the supplement; there is no placebo group.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- a food supplement containing mushroom extract, herbs, probiotics, and vitamins
- What this could lead to
- If it works, this could point toward a dietary supplement that supports vaginal health by promoting beneficial bacteria.
- What could go wrong
- This is a small, early study with no placebo group, so results may be due to chance or natural variation. The supplement is not a treatment for any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
30 people
The number who actually took part.
- Started
-
Jun 2025
- Finished
-
Mar 2026
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 45 years
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Female participants aged 18 to 45 years * Able and willing to provide written informed consent, participate in the study, and follow the study supplementation schedule and procedures * No symptoms, or only nonspecific symptoms not attributed to a diagnosed vaginal infection Exclusion Criteria: * Unexplained vaginal bleeding * Suspected or diagnosed cancer * Known intolerance, allergy, or hypersensitivity to any component of Hifas Intima Oral * An immunosuppressive disorder or human immunodeficiency virus infection * Current use of probiotics by any route of administration * A diagnosed specific vaginal infection or current treatment for a vaginal infection * A poorly controlled chronic noncommunicable disease, such as diabetes mellitus, Hashimoto thyroiditis, or heart disease * Pregnancy or planning to become pregnant * Premature menopause
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Microbiota are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Instituto Palacios, Salud y Medicina de la Mujer
Madrid, Madrid, 28009, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could gut bacteria predict infection risk in lymphedema?
- Iron pills may give female footballers a performance edge
- A fiber supplement may help perimenopausal women — a trial puts it to the test
- Gut check: can five friendly bacteria restore digestive balance?
- Could routine STI screening during pregnancy prevent preterm births?
- Could your vaginal bacteria decide if IVF works? scientists launch huge study.